CUBI, the Centro UOH de BioIngeniería, is at the forefront of precision oncology research in Chile. Focused on enhancing cancer treatment through personalized approaches, CUBI utilizes advanced genomic technologies, artificial intelligence, and preclinical models to create comprehensive molecular maps of prevalent cancers in the region of O'Higgins. This innovative infrastructure aims to improve clinical outcomes for cancer patients by understanding the biology of the disease and tailoring treatments accordingly.

In collaboration with leading global institutions like the IARC in France and the ICR in the UK, CUBI accelerates research progress and the implementation of cutting-edge cancer treatments. The center also supports the training of professionals in precision medicine, ensuring a robust workforce in this vital field. With initiatives such as the AIGEN 2026 workshop, CUBI is pioneering the integration of AI and genomics to advance public health. Their mission is to reduce cancer mortality and enhance patient care through scientific and technological advancements.